Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Loomba R"" wg kryterium: Autor


Wyświetlanie 1-20 z 20
Tytuł:
An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis.
Autorzy:
Zhao P; Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA. .
Sun X; Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Chaggan C; Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Liao Z; Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
In Wong K; Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
He F; Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Singh S; NAFLD Research Center, Division of Gastroenterology, Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Loomba R; NAFLD Research Center, Division of Gastroenterology, Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Karin M; Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Witztum JL; Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Saltiel AR; Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA. .; Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2020 Feb 07; Vol. 367 (6478), pp. 652-660.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
AMP-Activated Protein Kinases/*metabolism
Caspase 6/*metabolism
Liver/*enzymology
Liver/*pathology
Non-alcoholic Fatty Liver Disease/*enzymology
Non-alcoholic Fatty Liver Disease/*pathology
AMP-Activated Protein Kinases/genetics ; Animals ; Apoptosis/genetics ; Caspase 3/metabolism ; Caspase 7/metabolism ; Caspase Inhibitors/pharmacology ; Caspase Inhibitors/therapeutic use ; Enzyme Activation ; Hepatocytes/enzymology ; Hepatocytes/pathology ; Humans ; Mice ; Mice, Knockout ; Non-alcoholic Fatty Liver Disease/drug therapy ; Phosphorylation
Czasopismo naukowe
Tytuł:
Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trials.
Autorzy:
Pai RK; Scottsdale, AZ, USA.
Kleiner DE; Bethesda, MD, USA.
Hart J; Chicago, IL, USA.
Adeyi OA; Toronto, ON, Canada.
Clouston AD; Brisbane, Qld, Australia.
Behling CA; San Diego, CA, USA.
Jain D; New Haven, CT, USA.
Kakar S; San Francisco, CA, USA.
Brahmania M; London, ON, Canada.
Burgart L; Minneapolis, MN, USA.
Batts KP; Minneapolis, MN, USA.
Valasek MA; La Jolla, CA, USA.
Torbenson MS; Rochester, MN, USA.
Guindi M; Los Angeles, CA, USA.
Wang HL; Los Angeles, CA, USA.
Ajmera V; La Jolla, CA, USA.
Adams LA; Perth, WA, Australia.
Parker CE; London, ON, Canada.
Feagan BG; London, ON, Canada.
Loomba R; La Jolla, CA, USA.
Jairath V; London, ON, Canada.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2019 Nov; Vol. 50 (10), pp. 1100-1111. Date of Electronic Publication: 2019 Oct 03.
Typ publikacji:
Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Liver/*pathology
Non-alcoholic Fatty Liver Disease/*pathology
Practice Patterns, Physicians'/*standards
Randomized Controlled Trials as Topic/*standards
Research Design/*standards
Biopsy/methods ; Biopsy/standards ; Humans ; Image Interpretation, Computer-Assisted/methods ; Image Interpretation, Computer-Assisted/standards ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/pathology ; Randomized Controlled Trials as Topic/methods ; Reference Standards ; Reproducibility of Results ; Retrospective Studies ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł:
Relationship between three commonly used non-invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non-alcoholic steatohepatitis.
Autorzy:
Chalasani N; Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
Abdelmalek MF; Department of Medicine, Duke University, Durham, North Carolina.
Loomba R; Department of Medicine, University of California, San Diego, La Jolla, California.
Kowdley KV; Organ Transplant Center, Swedish Medical Center, Seattle, Washington.
McCullough AJ; Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio.
Dasarathy S; Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio.
Neuschwander-Tetri BA; Department of Internal Medicine, Saint Louis University, Saint Louis, Missouri.
Terrault N; Departments of Medicine and Surgery, University of California, San Francisco, San Francisco, California.
Ferguson B; Intercept Pharmaceuticals, Inc, San Diego, California.
Shringarpure R; Intercept Pharmaceuticals, Inc, San Diego, California.
Shapiro D; Intercept Pharmaceuticals, Inc, San Diego, California.
Sanyal AJ; Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2019 May; Vol. 39 (5), pp. 924-932. Date of Electronic Publication: 2019 Feb 21.
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers/*blood
Chenodeoxycholic Acid/*analogs & derivatives
Liver/*pathology
Liver Cirrhosis/*diagnosis
Non-alcoholic Fatty Liver Disease/*drug therapy
Adult ; Biopsy ; Chenodeoxycholic Acid/administration & dosage ; Female ; Humans ; Liver Cirrhosis/blood ; Liver Cirrhosis/etiology ; Logistic Models ; Male ; Middle Aged ; Non-alcoholic Fatty Liver Disease/blood ; Non-alcoholic Fatty Liver Disease/complications ; United States
Czasopismo naukowe
Tytuł:
A simple clinical model predicts incident hepatic steatosis in a community-based cohort: The Framingham Heart Study.
Autorzy:
Long MT; Section of Gastroenterology, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.; Framingham Heart Study, Framingham, MA, USA.
Pedley A; Framingham Heart Study, Framingham, MA, USA.; Merck Research Labs, Kenilworth, NJ, USA.
Massaro JM; Framingham Heart Study, Framingham, MA, USA.; Department of Mathematics and Statistics, Boston University, Boston, MA, USA.
Hoffmann U; Radiology Department, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Ma J; Framingham Heart Study, Framingham, MA, USA.; Population Sciences Branch, National Heart, Lung, and Blood Institute, Framingham, MA, USA.
Loomba R; NAFLD Research Center, Department of Medicine, University of California at San Diego, La Jolla, CA, USA.; Division of Epidemiology, Department of Family and Preventive Medicine, University of California at San Diego, La Jolla, CA, USA.; Division of Gastroenterology, Department of Medicine, University of California at San Diego, La Jolla, CA, USA.
Chung RT; Liver Center, Gastrointestinal Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Benjamin EJ; Framingham Heart Study, Framingham, MA, USA.; Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.; Cardiology and Preventive Medicine Sections, Evans Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2018 Aug; Vol. 38 (8), pp. 1495-1503. Date of Electronic Publication: 2018 Mar 12.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Fatty Liver/*diagnostic imaging
Fatty Liver/*epidemiology
Intra-Abdominal Fat/*diagnostic imaging
Liver/*diagnostic imaging
Adult ; Body Mass Index ; Boston/epidemiology ; Female ; Humans ; Incidence ; Liver/pathology ; Logistic Models ; Longitudinal Studies ; Male ; Middle Aged ; Multidetector Computed Tomography ; Multivariate Analysis ; Predictive Value of Tests ; ROC Curve ; Risk Factors ; Triglycerides/blood
Czasopismo naukowe
Tytuł:
Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD.
Autorzy:
Permutt Z; Division of Internal Medicine, Department of Medicine, University of California, San Diego, USA.
Le TA
Peterson MR
Seki E
Brenner DA
Sirlin C
Loomba R
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2012 Jul; Vol. 36 (1), pp. 22-9. Date of Electronic Publication: 2012 May 03.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Magnetic Resonance Imaging*
Fatty Liver/*diagnosis
Liver/*pathology
Liver Cirrhosis/*pathology
Adult ; Biopsy ; Cohort Studies ; Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Non-alcoholic Fatty Liver Disease ; Predictive Value of Tests ; Prospective Studies ; Severity of Illness Index
Czasopismo naukowe
Tytuł:
Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis.
Autorzy:
Boettcher E; Division of Gastroenterology, Department of Medicine, University of California at San Diego, La Jolla, CA 92093, USA.
Csako G
Pucino F
Wesley R
Loomba R
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2012 Jan; Vol. 35 (1), pp. 66-75. Date of Electronic Publication: 2011 Nov 04.
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Fatty Liver/*drug therapy
Hypoglycemic Agents/*therapeutic use
Liver/*drug effects
Liver Cirrhosis/*drug therapy
Thiazolidinediones/*therapeutic use
Fatty Liver/complications ; Humans ; Non-alcoholic Fatty Liver Disease ; Pioglitazone ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.
Autorzy:
Loomba R; Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA.
Lutchman G
Kleiner DE
Ricks M
Feld JJ
Borg BB
Modi A
Nagabhyru P
Sumner AE
Liang TJ
Hoofnagle JH
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2009 Jan; Vol. 29 (2), pp. 172-82. Date of Electronic Publication: 2008 Oct 09.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, N.I.H., Intramural
MeSH Terms:
Fatty Liver/*drug therapy
Hypoglycemic Agents/*therapeutic use
Liver/*drug effects
Metformin/*therapeutic use
Adult ; Biopsy ; Female ; Humans ; Male ; Middle Aged ; Pilot Projects ; Statistics as Topic ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Assessment of treatment response in non-alcoholic steatohepatitis using advanced magnetic resonance imaging.
Autorzy:
Lin, S. C.
Heba, E.
Bettencourt, R.
Lin, G. Y.
Valasek, M. A.
Lunde, O.
Hamilton, G.
Sirlin, C. B.
Loomba, R.
Pokaż więcej
Temat:
FATTY liver
THERAPEUTICS
LIVER
BIOMARKERS
HISTOLOGY
DIAGNOSIS
MAGNETIC resonance imaging
Źródło:
Alimentary Pharmacology & Therapeutics; 3/15/2017, Vol. 45 Issue 6, p844-854, 11p
Czasopismo naukowe
    Wyświetlanie 1-20 z 20

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies